I try to understand your analogy or comparison. While I agree with your assessment somewhat, but it’s a new recent acquisition / collaboration by Imugene, and one LC has openly stated that Precision Bio Azer Cel is the priority project to Imugene commercialisation.
Precision Bio investors can be excused for no announcement as they may have already known or expected but for me and others as Imugene investor it’s worthy news. And, it’s pretty critical news to me as MXCT technology will further improve cell engineering of our Azer Cel
kluck
MaxCyte and Imugene, page-65
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $443.4K | 8.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 3056419 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 120000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |